Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01081951
PHASE2

Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

To compare the efficacy of olaparib in combination with paclitaxel and carboplatin (AUC4) when compared with carboplatin (AUC6) and paclitaxel alone in patients with advanced ovarian cancer.

Official title: A Phase II Open Label Randomised Comparative Multicentre Study to Compare the Efficacy and Tolerability of Olaparib in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Platinum Sensitive Advanced Serous Ovarian Cancer

Key Details

Gender

FEMALE

Age Range

18 Years - 125 Years

Study Type

INTERVENTIONAL

Enrollment

162

Start Date

2010-02-04

Completion Date

2026-12-31

Last Updated

2026-02-05

Healthy Volunteers

No

Conditions

Interventions

DRUG

olaparib

Tablets Oral BID

DRUG

paclitaxel

175mg/m2 iv for 6 cycles (18 weeks) day 1 of 21 day cycle

DRUG

carboplatin

AUC6 iv for 6 cycles (18 weeks) day 1 of 21 day cycle

DRUG

paclitaxel

175mg/m2 iv for up to 6 cycles (18 weeks)

DRUG

Drug: carboplatin

AUC4 iv for up to 6 cycles (18 weeks)

Locations (53)

Research Site

Stanford, California, United States

Research Site

West Hollywood, California, United States

Research Site

Orlando, Florida, United States

Research Site

Indianapolis, Indiana, United States

Research Site

Boston, Massachusetts, United States

Research Site

Boston, Massachusetts, United States

Research Site

New York, New York, United States

Research Site

Portland, Oregon, United States

Research Site

Parkville, Australia

Research Site

Randwick, Australia

Research Site

Brussels, Belgium

Research Site

Leuven, Belgium

Research Site

Namur, Belgium

Research Site

Wilrijk, Belgium

Research Site

Vancouver, British Columbia, Canada

Research Site

Hamilton, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Québec, Quebec, Canada

Research Site

Sherbrooke, Quebec, Canada

Research Site

Brno, Czechia

Research Site

Brno, Czechia

Research Site

Hradec Králové, Czechia

Research Site

Olomouc, Czechia

Research Site

Prague, Czechia

Research Site

Essen, Germany

Research Site

Frankfurt, Germany

Research Site

Hamburg, Germany

Research Site

München, Germany

Research Site

Solingen, Germany

Research Site

Genova, Italy

Research Site

Milan, Italy

Research Site

Monza, Italy

Research Site

Torino, Italy

Research Site

Chūōku, Japan

Research Site

Fukuoka, Japan

Research Site

Matsuyama, Japan

Research Site

Morioka, Japan

Research Site

Shinjuku-ku, Japan

Research Site

Yamagata, Japan

Research Site

Yonago-shi, Japan

Research Site

Amsterdam, Netherlands

Research Site

Amsterdam, Netherlands

Research Site

Nijmegen, Netherlands

Research Site

Rotterdam, Netherlands

Research Site

Panama City, Panama

Research Site

Lima, Peru

Research Site

Lima, Peru

Research Site

Madrid, Spain

Research Site

Valencia, Spain

Research Site

Birmingham, United Kingdom

Research Site

Coventry, United Kingdom

Research Site

Edinburgh, United Kingdom